
Ligand Pharmaceuticals Incorporated LGND
$ 202.46
-0.56%
Quarterly report 2025-Q3
added 11-07-2025
Ligand Pharmaceuticals Incorporated Total Inventories 2011-2026 | LGND
Annual Total Inventories Ligand Pharmaceuticals Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 M | 24 M | 13.3 M | 27.3 M | 26.5 M | 7.3 M | 7.12 M | 4.37 M | 1.92 M | 1.63 M | 269 K | 1.39 M | 1.7 M | 1.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.3 M | 269 K | 9.44 M |
Quarterly Total Inventories Ligand Pharmaceuticals Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 M | 15.5 M | 14.6 M | 14.1 M | 16.7 M | 18.7 M | 21.3 M | 24 M | 25.4 M | 26.9 M | 14 M | 13.3 M | 22.3 M | 24.8 M | 25.6 M | 27.3 M | 33 M | 39.9 M | 36.9 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.12 M | 7.12 M | 7.12 M | 7.12 M | 4.37 M | 4.37 M | 4.37 M | 4.37 M | 1.92 M | 1.92 M | 1.92 M | 1.92 M | 1.63 M | 1.63 M | 1.63 M | 1.63 M | 269 K | 269 K | 269 K | 269 K | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 39.9 M | 269 K | 10.9 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.35 | -2.88 % | $ 359 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.57 | -3.57 % | $ 16.1 M | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.61 | -3.89 % | $ 189 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 314.88 | -4.68 % | $ 41.3 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.91 | 2.52 % | $ 4.96 M | ||
|
Cerus Corporation
CERS
|
56.1 M | $ 1.84 | -0.81 % | $ 351 M | ||
|
AbbVie
ABBV
|
4.95 B | $ 202.58 | -1.96 % | $ 358 B | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.03 | -1.59 % | $ 431 M | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.31 | -2.36 % | $ 989 M |